LIGAND PHARMACEUTICALS INCORPORATED Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 346.01 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-07
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 28.20K shares, a 44.91% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 317.81K shares, a 21.76% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 11.50K shares, a 72.65% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 468.88K shares, a 40.12% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 783.06K shares, a 45.70% increase from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 537.43K shares.
- LIGAND PHARMACEUTICALS INCORPORATED share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 393.59K shares, a 51.19% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 2 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 10 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 28.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 346.01K shares 10-Q · filed 2026-08-07 | 346.01K shares derived: sum of 3 quarters · filed 2026-08-07 | 357.51K shares derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | 317.81K shares 10-Q · filed 2026-05-08 | 317.81K shares derived: sum of 2 quarters · filed 2026-05-08 | 329.31K shares derived: sum of 3 quarters · filed 2026-05-08 | 380.50K shares derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 11.50K shares derived: sum of 2 quarters · filed 2026-02-27 | 62.70K shares derived: sum of 3 quarters · filed 2026-02-27 | 468.88K shares 10-K · filed 2026-02-27 | |||
| 2025-09-30 | 11.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 62.70K shares derived: sum of 2 quarters · filed 2025-11-07 | 468.88K shares 10-Q · filed 2025-11-07 | 508.82K shares derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2025-06-30 | 51.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 457.38K shares 10-Q · filed 2025-08-08 | 497.32K shares derived: sum of 3 quarters · filed 2026-02-27 | 539.38K shares derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2025-03-31 | 406.18K shares 10-Q · filed 2025-05-09 | 446.13K shares derived: sum of 2 quarters · filed 2026-02-27 | 488.18K shares derived: sum of 3 quarters · filed 2026-02-27 | 591.10K shares derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-12-31 | 39.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 82.00K shares derived: sum of 2 quarters · filed 2026-02-27 | 184.92K shares derived: sum of 3 quarters · filed 2026-02-27 | 783.06K shares 10-K · filed 2026-02-27 | |||
| 2024-09-30 | 42.05K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | 144.97K shares derived: sum of 2 quarters · filed 2024-11-08 | 743.12K shares 10-Q · filed 2024-11-08 | 762.22K shares derived: sum of 4 quarters · filed 2026-02-27 | |||
| 2024-06-30 | 102.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 701.06K shares 10-Q · filed 2024-08-07 | 720.16K shares derived: sum of 3 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | 598.14K shares 10-Q · filed 2024-05-08 | 617.24K shares derived: sum of 2 quarters · filed 2026-02-27 | |||||
| 2023-12-31 | 19.10K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 537.43K shares 10-K · filed 2026-02-27 | |||||
| 2023-09-30 | 518.33K shares 10-Q · filed 2023-11-09 | ||||||
| 2022-12-31 | 3.58M shares 10-K · filed 2025-02-28 | ||||||
| 2022-10-31 | 863.25K shares 10-K · filed 2025-02-28 | ||||||
| 2021-12-31 | 393.59K shares 10-K · filed 2024-02-29 | ||||||
| 2020-12-31 | 806.30K shares 10-K · filed 2023-02-28 | ||||||
| 2019-12-31 | 338.62K shares 10-K · filed 2022-02-28 | ||||||
| 2018-12-31 | 228.36K shares 10-K · filed 2021-02-24 | ||||||
| 2018-06-30 | 21.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 224.31K shares 10-Q · filed 2018-08-08 | 295.11K shares derived: sum of 3 quarters · filed 2018-08-08 | 299.56K shares derived: sum of 4 quarters · filed 2018-08-08 | |||
| 2018-03-31 | 202.99K shares 10-Q · filed 2018-05-09 | 273.79K shares derived: sum of 2 quarters · filed 2018-05-09 | 278.25K shares derived: sum of 3 quarters · filed 2018-05-09 | 295.58K shares derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2017-12-31 | 70.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 75.25K shares derived: sum of 2 quarters · filed 2018-03-01 | 92.59K shares derived: sum of 3 quarters · filed 2018-03-01 | 273.35K shares 10-K · filed 2018-03-01 | |||
| 2017-09-30 | 4.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 21.79K shares derived: sum of 2 quarters · filed 2017-11-09 | 202.55K shares 10-Q · filed 2017-11-09 | 202.55K shares derived: sum of 4 quarters · filed 2017-11-09 | |||
| 2017-06-30 | 17.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 198.10K shares 10-Q · filed 2017-08-09 | 198.10K shares derived: sum of 3 quarters · filed 2017-08-09 | 206.60K shares derived: sum of 4 quarters · filed 2017-08-09 | |||
| 2017-03-31 | 180.76K shares 10-Q · filed 2017-05-09 | 180.76K shares derived: sum of 2 quarters · filed 2017-05-09 | 189.26K shares derived: sum of 3 quarters · filed 2017-05-09 | 203.24K shares derived: sum of 4 quarters · filed 2017-05-09 | |||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | 8.50K shares derived: sum of 2 quarters · filed 2017-02-28 | 22.47K shares derived: sum of 3 quarters · filed 2017-02-28 | 263.49K shares 10-K · filed 2017-02-28 | |||
| 2016-09-30 | 8.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 22.47K shares derived: sum of 2 quarters · filed 2016-11-14 | 263.49K shares 10-Q · filed 2016-11-14 | 263.49K shares derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2016-06-30 | 13.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-14 | 254.99K shares 10-Q · filed 2016-11-14 | 254.99K shares derived: sum of 3 quarters · filed 2016-11-14 | 279.99K shares derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2016-03-31 | 241.01K shares 10-Q · filed 2016-11-14 | 241.01K shares derived: sum of 2 quarters · filed 2016-11-14 | 266.01K shares derived: sum of 3 quarters · filed 2016-11-14 | 285.29K shares derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14 | 25.00K shares derived: sum of 2 quarters · filed 2016-11-14 | 44.28K shares derived: sum of 3 quarters · filed 2016-11-14 | 287.75K shares 10-K · filed 2016-11-14 | |||
| 2015-09-30 | 25.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | 44.28K shares derived: sum of 2 quarters · filed 2015-11-09 | 287.75K shares 10-Q · filed 2015-11-09 | 311.50K shares derived: sum of 4 quarters · filed 2015-11-09 | |||
| 2015-06-30 | 19.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | 262.75K shares 10-Q · filed 2015-08-05 | 286.50K shares derived: sum of 3 quarters · filed 2015-08-05 | 286.50K shares derived: sum of 4 quarters · filed 2015-08-05 | |||
| 2015-03-31 | 243.47K shares 10-Q · filed 2015-05-11 | 267.22K shares derived: sum of 2 quarters · filed 2015-05-11 | 267.22K shares derived: sum of 3 quarters · filed 2015-05-11 | 301.40K shares derived: sum of 4 quarters · filed 2015-05-11 | |||
| 2014-12-31 | 23.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | 23.75K shares derived: sum of 2 quarters · filed 2015-02-23 | 57.93K shares derived: sum of 3 quarters · filed 2015-02-23 | 389.93K shares 10-K · filed 2015-02-23 | 439.93K shares 10-K · filed 2014-12-01 | ||
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | 34.18K shares derived: sum of 2 quarters · filed 2014-10-31 | 366.18K shares 10-Q · filed 2014-10-31 | 366.18K shares derived: sum of 4 quarters · filed 2014-12-12 | |||
| 2014-06-30 | 34.18K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | 366.18K shares 10-Q · filed 2014-08-05 | 366.18K shares derived: sum of 3 quarters · filed 2014-12-12 | 368.68K shares derived: sum of 4 quarters · filed 2014-12-12 | |||
| 2014-03-31 | 332.00K shares 10-Q · filed 2014-05-07 | 332.00K shares derived: sum of 2 quarters · filed 2014-12-12 | 334.50K shares derived: sum of 3 quarters · filed 2014-12-12 | 400.18K shares derived: sum of 4 quarters · filed 2014-12-12 | |||
| 2013-12-31 | 0.00 shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | 2.50K shares derived: sum of 2 quarters · filed 2014-12-12 | 68.18K shares derived: sum of 3 quarters · filed 2014-12-12 | 439.93K shares 10-K/A · filed 2014-12-12 | |||
| 2013-09-30 | 2.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | 68.18K shares derived: sum of 2 quarters · filed 2013-11-08 | 439.93K shares 10-Q · filed 2013-11-08 | 443.93K shares derived: sum of 4 quarters · filed 2014-12-12 | |||
| 2013-06-30 | 65.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | 437.43K shares 10-Q · filed 2013-08-01 | 441.43K shares derived: sum of 3 quarters · filed 2014-12-12 | 508.93K shares derived: sum of 4 quarters · filed 2014-12-12 | |||
| 2013-03-31 | 371.75K shares 10-Q · filed 2013-05-08 | 375.75K shares derived: sum of 2 quarters · filed 2014-12-12 | 443.25K shares derived: sum of 3 quarters · filed 2014-12-12 | ||||
| 2012-12-31 | 4.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | 71.50K shares derived: sum of 2 quarters · filed 2014-12-12 | 714.35K shares 10-K/A · filed 2014-12-12 | ||||
| 2012-09-30 | 67.50K shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | 710.35K shares 10-Q · filed 2012-11-14 | |||||
| 2012-06-30 | 642.85K shares 10-Q/A · filed 2012-11-14 | ||||||
| 2011-12-31 | 636.58K shares 10-K/A · filed 2014-12-12 | ||||||
| 2010-12-31 | 248.20K shares 10-K · filed 2013-03-14 |